Add like
Add dislike
Add to saved papers

Molecular epidemiology of penicillinase-producing Neisseria gonorrhoeae isolates and their bla TEM-135 gene variant in Bangkok, Thailand, 2015-2017.

Penicillinase-producing Neisseria gonorrhoeae (PPNG) possessing blaTEM-135 is a serious public health threat. With only a single change in amino acid sequence, blaTEM-135 could evolve into TEM-type extended-spectrum beta-lactamase (ESBL), which hydrolyzes extended-spectrum cephalosporins, including ceftriaxone and cefixime. We investigated the molecular epidemiological characteristics, types of plasmids of PPNG isolates, and prevalence of PPNG clinical isolates producing TEM-135 beta-lactamases. N. gonorrhoeae multiantigen sequence typing (NG-MAST) was used to determine the molecular epidemiological characteristics of 99 PPNG isolates collected from 2015 to 2017. A mismatch amplification mutation assay examined the blaTEM-135 gene prevalence. Of 89 NG-MAST sequence types identified, 65 (73.0%) were novel. Only 17.7% (43/243) of the PPNG isolates belonged to 16 genogroups. The most frequent plasmid was African, followed by Rio/Toronto and Asian. The blaTEM-135 allele was in Rio/Toronto plasmids. The blaTEM-135 allele was present in 23.2% (23/99) of PPNG isolates. PPNG isolates expressing TEM-135 beta-lactamase exhibited significantly higher penicillin MIC values than TEM-1 PPNG isolates. PPNG isolates showed high genetic diversity and high proportions of blaTEM-135 alleles. Mutation of the blaTEM-135 allele is worrisome: only 1 mutation could see TEM-1 evolve into an ESBL variant degrading ceftriaxone. Ongoing surveillance of blaTEM-135 and new PPNG isolate variants is imperative.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app